Molecular Skincare Overview

  • Founded
  • 2001
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A

Molecular Skincare General Information


Developer of novel dermatology products. The company develops novel treatments for dermatological and allergy-based disorders, such as psoriasis and eczema.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Drug Discovery
York Pharma
Primary Office
  • Sheffield
  • England, United Kingdom
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Molecular Skincare Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 01-Feb-2005 00.000 Completed Generating Revenue
1. Early Stage VC 01-Mar-2002 00.000 00.000 Completed Product Development
To view Molecular Skincare’s complete valuation and funding history, request access »

Molecular Skincare Former Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Catalyst Biomedica Corporation Minority 000 0000 000000 0
Sitka Partners Venture Capital Minority 000 0000 000000 0
University of Cambridge Endowment Limited Partner Minority 000 0000 000000 0
To view Molecular Skincare’s complete investors history, request access »